StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.35+0.14 (+0.99%)

Close on Nov 18, 2026Market cap $38.31MP/E –Yield –

Yarrow Bioscience market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Yarrow Bioscience's market cap was $12.06M on Nov 11, 2026, against $7.62M a year earlier. Over the last 5 years it ranged from $5.65M to $54.58M, with a median of $20.01M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$12.06M+5.2%
2025Dec 31, 2025$11.47M-76.8%
2024Dec 31, 2024$49.42M+541.8%
2023Dec 29, 2023$7.70M-11.5%
2022Dec 30, 2022$8.70M-84.1%
2021Dec 31, 2021$54.58M-79.4%
2020Dec 31, 2020$265.20M+138.3%
2019Dec 31, 2019$111.27M+16.3%
2018Dec 31, 2018$95.70M–

More Yarrow Bioscience figures

See a number that looks wrong?